In de VS – FDA keurt CBD-rijk cannabisextract goed voor behandeling Epilepsie
14 jul
IMPORTANT NEWS!
US: FDA keurt CBD-rijk cannabisextract goed voor behandeling Epilepsie
13 juli 2018
Voor het eerst in de geschiedenis van de US is een medicijn gemaakt van cannabis goedgekeurd door de FDA. (Food and Drug Administration).
VS: Gezondheidsdienst keurt CBD-rijk cannabisextract goed voor de behandeling van epilepsie
De VS gezondheidsregulators voor medicinale drugs heeft GW Pharmaceuticals epilepsie cannabis-gebaseerde medicijn op 25 juni goedgekeurd voor de behandeling van bepaalde vormen van epilepsie, waardoor het het eerste op cannabis-gebaseerd medicijn is, die deze goedkeuring heeft in het land. “De goedkeuring dient als een herinnering dat de bevordering van gezonde ontwikkelings programma’s die goed werkzame bestanddelen die cannabis bevat evalueren en tot belangrijke medische therapieën kunnen leiden,” zei Scott Gottlieb van de Food and Drug Administration.
Het gebruik van het medicijn heeft goedkeuring bij patiënten in de leeftijd van twee jaar en ouder met het Dravet-syndroom en het syndroom van Lennox-Gastaut, die tot de zeldzame kinder-begin vormen van epilepsie behoren, die het meest resistent zijn tegen behandeling. Het medicijn, Epidiolex, bevat cannabidiol (CBD) en minder dan 0,1% van de THC.
USA: Health authority approves CBD-rich cannabis extract for the treatment of epilepsy
The U.S. health regulator for medicinal drugs approved GW Pharmaceuticals epilepsy cannabis-based drug on 25 June for the treatment of certain forms of epilepsy, making it the first cannabis-based drug to win approval in the country. “This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies,” said Scott Gottlieb of the Food and Drug Administration.
The drug’s approval permits its use in patients aged two years and older with Dravet Syndrome and Lennox-Gastaut Syndrome, rare childhood-onset forms of epilepsy that are among the most resistant to treatment. The drug, Epidiolex, contains cannabidiol (CBD) and less than 0.1% of THC.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duur
Beschrijving
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.